Skip to main content
OpenTrials

Clinical trial condition

Hypopharyngeal Neoplasms

Explore clinical trials studying Hypopharyngeal Neoplasms. Study availability and eligibility vary by location and protocol.

102 public trials 27 recruiting studies
Refine in advanced search Browse all conditions

Hypopharyngeal Neoplasms trial results

Completed

Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin

NCT03258554

Conditions
Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +38 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • CTCA at Western Regional Medical Center Goodyear, Arizona, United States
View all 256 locations
View Trial Details
Completed

Trial of Acupuncture for Radiation-Induced Xerostomia in Head and Neck Cancer

NCT02589938

Conditions
Head and Neck Cancer, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, +24 more
Locations
  • Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California, United States
  • Kaiser Permanente-San Francisco San Francisco, California, United States
  • Kaiser Permanente-Santa Teresa-San Jose San Jose, California, United States
  • Kaiser Permanente-San Rafael San Rafael, California, United States
View all 36 locations
View Trial Details
Completed

Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma

NCT03082534

Conditions
Carcinoma, Carcinoma, Squamous Cell, Cutaneous Squamous Cell Carcinoma, +37 more
Locations
  • UCSD Moores Cancer Center La Jolla, California, United States
  • University of California Los Angeles Cancer Center Los Angeles, California, United States
  • University of Michigan Cancer Center Ann Arbor, Michigan, United States
  • Washington School of Medicine Cancer Center St Louis, Missouri, United States
View Trial Details

Related conditions